お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
747167

世界のウェアラブルインジェクター市場:タイプ、技術、用途、エンドユーザー別の予測

Global Wearable Injectors Market Size, by Type (Body-Worn Patch Injector, Off-Body Worn Belt Injector and Bolus Injector), by Technology (Electronic Injector, Mechanical Injector and Others), by Application, by End User and Forecast, 2024

出版日: | 発行: Blueweave Consulting & Research Private Limited | ページ情報: 英文 200 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
世界のウェアラブルインジェクター市場:タイプ、技術、用途、エンドユーザー別の予測
出版日: 2018年11月21日
発行: Blueweave Consulting & Research Private Limited
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のウェアラブルインジェクター市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルと競合動向についてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 市場見通し

  • イントロダクション
  • 市場の機会
  • 市場成長促進因子と市場予測への影響
  • 市場成長阻害因子

第4章 市場規模と予測

第5章 タイプ別市場

  • 装着式パッチインジェクター
  • 非装着式ベルトインジェクター
  • ボーラスインジェクター

第6章 技術別市場

  • 電子式
  • 機械式

第7章 用途別市場

  • 感染症
  • 自己免疫疾患
  • 心血管疾患
  • 血液疾患

第8章 エンドユーザー別市場

  • 在宅ケア
  • 病院
  • 試験所・診断

第9章 地域別市場規模と予測

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ

第10章 競合環境

  • ポーターズファイブフォース分析
  • 競合ポジショニング
  • 競合ベンチマーキング
  • 市場シェア分析
  • 企業プロファイル
  • 戦略的発展
  • 略語リスト
目次
Product Code: BWC1841

Global Wearable Injectors Market: Overview

Global Wearable Injectors market report provides analysis for the period 2012-2024. The market study reveals that the Global Wearable Injectors market is projected to rise over a CAGR of 24.53% during 2018-2024 in terms of value. This growth is driven by rising usage of advance drug delivery devices at home. Rise in prevalence of chronic diseases among old age population is surging the demand for wearable injector's products over the projected timeframe.

The market overview section of the report demonstrates market dynamics such as, drivers and restraints that talks about the current nature and future scenario of the said market, key market indicators and raw material analysis. End-user segment comprises of homecare, hospital, lab & diagnostics, other. Further, key market indicators included in the report provide the significant factors which are capable to define the market position of Global Wearable Injectors Market. Furthermore, various analysis methods like Porter's, Pestle are also included in the report to provide an in-depth view of the market scenario.

Global Wearable Injectors Market: Key Findings of the Report

According to BlueWeave Consulting, the key findings of the report "Global Wearable Injectors Market Product, Technology, End-user, Application, Growth and Demand Forecast to 2024" are:

  • The demand for Global Wearable Injectors market is expected to grow at a significant rate, during forecast period. Wearable Injectors is witnessing tremendous growth owing to increasing life expectancy and fall in birth rates increasing old age population. The elderly population requires extensive care, as they are prone to illness due to low immunity levels and high recovery time. The elderly people are more susceptible to chronic diseases, such as cancer, diabetes, neurological disorders and cardiovascular diseases, thus increasing the usage of wearable injectors across the globe.
  • Body-worn patch injectors are the largest contributor, in terms of value, as compared to Off-body worn belt injectors. It is expected to rise with CAGR over 6.9% by value during the forecast period, 2018-2024.
  • Global Wearable Injectors market for technology segment, electronic injectors being the highest revenue generator, with a market share of 54.76% in 2017
  • North America is the fastest growing region in the Wearable Injectors market and is expected to propel with a CAGR over 24.48% by value during the forecast period, 2018-2024. Japan being the fastest growing country having a CAGR over 25.1% and expected to reach revenue of around USD 1,170.4 million by the end of 2024.

Global Wearable Injectors Market: Key Stakeholders

  • Becton, Dickinson, and Company
  • Medtronic plc
  • Johnson & Johnson
  • F. Hoffmann-La Roche Lt

Global Wearable Injectors Market: Research Methodology

Extensive secondary research was conducted using paid data sources including Bloomberg, Factiva, Capital IQ, OneSource, and Hoovers. Additionally, several publicly-available data sources were used including journals, statistics articles, and industry associations. These data sources were used to gather relevant information to develop an understanding on the global Wearable Injectors market. The research was conducted covering the desk research and primary research. Data sources used for primary research included online forums and blogs, CATI/CAWI, CAPI interviews, and video conferences. Additionally, interviews were conducted through connecting with various industry respondents including C-level executives, directors, divisional heads, regional heads, expert consultants, and independent consultants. The primary research was conducted to gain market insights from industry respondents and validate the gathered information through desk research.

Global Wearable Injectors Market: Competitive Dynamics

The Global Wearable Injectors market is dominated by a number of players, amongst them the major players are Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, nilife Corporation, CeQur SA, etc. Companies in this industry are following different strategies to strengthen their market position.

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Market Definition
  • 1.2 Research Scope
    • 1.2.1 Global wearable injector market, by type
    • 1.2.2 Global wearable injector market, by technology
    • 1.2.3 Global wearable injector market, by application
    • 1.2.4 Global wearable injector market, by end user
    • 1.2.5 Global wearable injector market, by geography
  • 1.3 Research Approach and Sources

Chapter 2. Executive Summary

  • 2.1 Key Findings
  • 2.2 Research Summary

Chapter 3. Market Outlook

  • 3.1 Introduction
  • 3.2 Global Wearable Injectors Market Opportunities
    • 3.2.1 High usage of wearable injectors in emerging markets
  • 3.3 Factors Driving the Growth of the Market and its Impact on Market Forecast
    • 3.3.1 Ageing population
    • 3.3.2 Accelerating pervasiveness of chronic diseases
    • 3.3.3 Growing demand for advance drug delivery
    • 3.3.4 Rise in pipeline for biologic drugs
    • 3.3.5 Market analysis of drivers over forecast period
  • 3.4 Restraning Factors hindering market growth
    • 3.4.1 Alternative drug delivery methods
    • 3.4.2 Disadvantage of wearable injector
    • 3.4.3 Market challenges analysis on market forecast

Chapter 4. Global Wearable Injectors Market Size and Forecast (2012 - 2024)

  • 4.1 Global Wearable Injectors Market, by Type
  • 4.2 Global Wearable Injectors Market, by Technology
  • 4.3 Global Wearable Injectors Market, by Application
  • 4.4 Global Wearable Injectors Market, by End User
  • 4.5 Global Wearable Injectors Market, by Region

Chapter 5. Global Wearable Injectors Market, by Type

  • 5.1 Body-Worn Patch Injector Market
    • 5.1.1 Global body-worn patch injector market, by region
  • 5.2 Off-Body Worn Belt Injector Market
    • 5.2.1 Global off-body worn belt injector market, by region
  • 5.3 Bolus Injector Market
    • 5.3.1 Global bolus injector market, by region

Chapter 6. Global Wearable Injectors Market, by Technology

  • 6.1 Electronic Wearable Injector Market
    • 6.1.1 Global electronic wearable injector market, by region
  • 6.2 Mechanical Wearable Injector Market
    • 6.2.1 Global mechanical wearable injectors market, by region

Chapter 7. Global Wearable Injectors Market, by Application

  • 7.1 Wearable Injector Market for Cancer
    • 7.1.1 Global wearable injector market for cancer, by region
  • 7.2 Wearable Injector Market for Infectious Disease
    • 7.2.1 Global wearable injector market for infectious disease, by region
  • 7.3 Wearable Injector Market for Autoimmune Disorder
    • 7.3.1 Global wearable injectors for autoimmune disorder, by region
  • 7.4 Wearable Injectors Market for Cardiovascular Disease
    • 7.4.1 Global wearable injector market for cardiovascular disese, by region
  • 7.5 Wearable Injectors Market for Blood Disorder
  • 7.6 Global wearable injector for blood disorder, by region

Chapter 8. Global Wearable Injectors Market, by End User

  • 8.1 Wearable Injector Market in Homecare
  • 8.2 Global wearable injector market in homecare, by region
  • 8.3 Wearable Injector Market in Hospital
  • 8.4 Global wearable injector market in hospital, by region
  • 8.5 Wearable Injector Market in Lab & Diagnostics
  • 8.6 Global wearable injector market in lab & diagnostics, by region

Chapter 9. Global Wearable Injectors Market, by Geography

  • 9.1 North America Wearable Injector Market
    • 9.1.1 North America wearable injector market, by type
    • 9.1.2 North America wearable injector market, by technology
    • 9.1.3 North America wearable injectors market, by application
    • 9.1.4 North America wearable injector market, by end user
    • 9.1.5 North America wearable injector market, by country
  • 9.2 Latin America Wearable Injector Market
    • 9.2.1 Latin America wearable injectors market, by type
    • 9.2.2 Latin America wearable injector market, by technology
    • 9.2.3 Latin America wearable injector market, by application
    • 9.2.4 Latin America wearable injector market, by end user
    • 9.2.5 Latin America wearable injector market, by country
  • 9.3 Europe Wearable Injector Market
    • 9.3.1 Europe wearable injector market, by type
    • 9.3.2 Europe wearable injector market, by technology
    • 9.3.3 Europe wearable injector market, by application
    • 9.3.4 Europe wearable injector market, by end user
    • 9.3.5 Europe wearable injector market, by country
  • 9.4 APAC Wearable Injector Market
    • 9.4.1 APAC wearable injector market, by type
    • 9.4.2 APAC wearable injector market, by technology
    • 9.4.3 APAC wearable injector market, by application
    • 9.4.4 APAC wearable injector market, by end user
    • 9.4.5 APAC wearable injector market, by country
  • 9.5 MEA Wearable Injector Market
    • 9.5.1 MEA wearable injector market, by type
    • 9.5.2 MEA wearable injector market, by technology
    • 9.5.3 MEA wearable injector market, by application
    • 9.5.4 MEA wearable injector market, by end user

Chapter 10. Competitive Landscape

  • 10.1 Porters Five Forces of Competitive Position Analysis
    • 10.1.1 Bargaining power of buyers
    • 10.1.2 Bargaining power of suppliers
    • 10.1.3 Threat of new entrants
    • 10.1.4 Intensity of rivalry
    • 10.1.5 Threat of substitutes
  • 10.2 Competitive Positioning of the Global Wearable Injectors Market, by Type
  • 10.3 Competitive Benchmarking Of the Key Players in the Global Wearable Injectors Market, by Type
  • 10.4 Market Share Analysis of the Global Wearable Injectors Market
  • 10.5 Company Profiles
    • 10.5.1 Becton, Dickinson and Company
      • 10.5.1.1 Business overview
      • 10.5.1.2 Product and service offerings
    • 10.5.2 Medtronic plc
      • 10.5.2.1 Business overview
      • 10.5.2.2 Product and service offerings
    • 10.5.3 Johnson & Johnson
      • 10.5.3.1 Business overview
      • 10.5.3.2 Product and service offerings
    • 10.5.4 F. Hoffmann-La Roche Ltd.
      • 10.5.4.1 Business overview
      • 10.5.4.2 Product and service offerings
    • 10.5.5 Unilife Corporation
      • 10.5.5.1 Business overview
      • 10.5.5.2 Product and service offerings
    • 10.5.6 CeQur SA
      • 10.5.6.1 Business overview
      • 10.5.6.2 Product and service offerings
    • 10.5.7 Sensile Medical AG
      • 10.5.7.1 Business overview
      • 10.5.7.2 Product and service offerings
    • 10.5.8 Enable Injections
      • 10.5.8.1 Business overview
      • 10.5.8.2 Product and service offerings
    • 10.5.9 ScPharmaceuticals, Inc.
      • 10.5.9.1 Business overview
      • 10.5.9.2 Product and service offerings
    • 10.5.10 SteadyMed Ltd.
      • 10.5.10.1 Business overview
      • 10.5.10.2 Product and service offerings
    • 10.5.11 Insulet Corporation
      • 10.5.11.1 Business overview
      • 10.5.11.2 Product and service offerings
    • 10.5.12 Ypsomed Group
      • 10.5.12.1 Business overview
      • 10.5.12.2 Product and service offerings
    • 10.5.13 West Pharmaceutical Services, Inc.
      • 10.5.13.1 Business overview
      • 10.5.13.2 Product and service offerings
    • 10.5.14 Buhler Motor GmbH
      • 10.5.14.1 Business overview
      • 10.5.14.2 Product and service offerings
    • 10.5.15 Cane S.p.A.
      • 10.5.15.1 Business overview
      • 10.5.15.2 Product and service offerings
  • 10.6 Strategic Developments in the Global Wearable Injectors Market
  • 10.7 List of Abbreviations 102
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.